Stanex Drugs And Chemicals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2004.
2004 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Stanex Drugs And Chemicals Private Limited

Stanex Drugs And Chemicals Private Limited, a active private limited company, was established on 28 December 2004 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24239TG2004PTC044988. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.75 Cr.

It upholds a compliant status. Employing 46 professional, Its leadership includes Yella Reddy Kamireddy (Director), Sridevi Kamireddy (Director), Bhagavan Reddy Kamireddy (Managing Director). Past directors included Yella Reddy Kamireddy, Ramalinga Reddy Sudini. It holds ₹25.41 Cr open charges and ₹5.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.N.16-140/1, Street No: 3Prashanti Nagar Uppal, Hyderabad, Telangana, 500039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2004PTC044988

  • Registration Number

    044988

  • Incorporation Date

    28 December 2004

  • Authorized Capital

    ₹1.75 Cr

  • Paid-Up Capital

    ₹1.75 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.75 Cr
  • Paid Up Capital ₹ 1.75 Cr
  • Company Age 21 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 25.41 Cr
  • Satisfied Charges ₹ 5.45 Cr
  • Revenue Growth **** -17.74%
  • Profit Growth **** 27.69%
  • Ebitda **** 48.79%
  • Net Worth 17.85%
  • Total Assets -47.11%
Company report

Stanex Drugs And Chemicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Stanex Drugs And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Stanex Drugs And Chemicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Yella Reddy Kamireddy Director 28 Dec 2004 Current
Sridevi Kamireddy Director 28 Dec 2004 Current
Bhagavan Reddy Kamireddy Managing Director 28 Dec 2004 Current
Nitya Kamireddy Director 29 Apr 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jul 2024 Past
Pramod Abcsdd Director 29 Apr 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Stanex Drugs And Chemicals.

Stanex Drugs And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.74% decrease. The company also saw a substantial improvement in profitability, with a 27.69% increase in profit. The company's net worth Soared by an impressive increase of 17.85%.

Stanex Drugs And Chemicals revenue growth over time
Stanex Drugs And Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.74%
*******
*******
*******
*******
Revenue from Operations
*******
 -17.80%
*******
*******
*******
*******
Total Assets
*******
 -47.11%
*******
*******
*******
*******
Profit or Loss
*******
 27.69%
*******
*******
*******
*******
Net Worth
*******
 17.85%
*******
*******
*******
*******
EBITDA
*******
 48.79%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Stanex Drugs And Chemicals?

In 2023, Stanex Drugs And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹254,118,321.00

Satisfied Charges

₹54,500,000.00

Charges Breakdown by Lending Institutions
  • Others : 25.32 Cr
  • Hdfc Bank Limited : 0.09 Cr
Latest Charge Details
Date Lender Amount Status
31 May 2025 Others ₹9.67 M Open
30 Dec 2024 Others ₹7.73 M Open
28 Mar 2022 Others ₹2.58 M Open
23 Sep 2021 Others ₹20.64 Cr Open
29 Apr 2020 Others ₹6.83 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Stanex Drugs And Chemicals?

Stanex Drugs And Chemicals has a workforce of 46 employees as of Sep 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Stanex Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanex Drugs And Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Stanex Drugs And Chemicals
Recent Activity within the Organization
  • Charges

    A charge with Others amounted to Rs. 0.97 Cr with Charge ID 101109412 was registered on 31 May 2025. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 0.77 Cr with Charge ID 101037578 was registered on 30 Dec 2024. was completed.

  • Annual General Meeting

    The activity Stanex Drugs And Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Stanex Drugs And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge with Others of Rs. 20.64 Cr registered on 23 Sep 2021 with Charge ID 100488750 was modified on 16 Mar 2024. was completed.

  • Director Appointment

    Nitya Kamireddy was appointed as a Director was appointed as a Director on 29 Apr 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Stanex Drugs And Chemicals Private Limited?

The CIN of Stanex Drugs And Chemicals Private Limited is U24239TG2004PTC044988.

Where is Stanex Drugs And Chemicals Private Limited headquartered?

Stanex Drugs And Chemicals Private Limited is headquartered at D.N.16-140/1, Street No: 3Prashanti Nagar Uppal, Hyderabad, Telangana, 500039.

When was Stanex Drugs And Chemicals Private Limited incorporated?

Stanex Drugs And Chemicals Private Limited was incorporated on 28 December 2004.

Who are the current directors of Stanex Drugs And Chemicals Private Limited?

The current directors of Stanex Drugs And Chemicals Private Limited are

What is the primary industry of Stanex Drugs And Chemicals Private Limited?

The primary industry of Stanex Drugs And Chemicals Private Limited is Manufacturing.

Is Stanex Drugs And Chemicals Private Limited a listed company?

Stanex Drugs And Chemicals Private Limited is unlisted.

What is the capital structure of Stanex Drugs And Chemicals Private Limited?

The authorized capital of Stanex Drugs And Chemicals Private Limited is ₹1.75 Cr, and the paid-up capital is ₹1.75 Cr.

What is the compliance status of Stanex Drugs And Chemicals Private Limited?

The compliance status of Stanex Drugs And Chemicals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available